- Breaking News San Mateo County ninth-graders struggle to stay fit
- Breaking News Food and wine events
- Breaking News Ask Amy: What To Do When the Doctor Isn t in the House
- Breaking News Ed Blonz: Keep your diet normal pre-surgery
Genzyme Begins Phase 2 Pivotal Study of Clolar(R) and Caliper Collaborates with Invitrogen to Develop Fluorescence Kits for Optical Imaging.
0 Comments | M2 Presswire, November, 2006
M2 PRESSWIRE-29 November 2006-U.S. Equity News: Genzyme Begins Phase 2 Pivotal Study of Clolar(R) and Caliper Collaborates with Invitrogen to Develop Fluorescence Kits for Optical Imaging(C)1994-2006 M2 COMMUNICATIONS LTD RDATE:29112006 City of Industry, CA - Biotechnology industry alert provided by U.S.
Equity News. Genzyme Corporation (Nasdaq: GENZ) recently announced that it has begun treating patients in a phase 2 clinical trial examining the safety and effectiveness of Clolar (clofarabine) in previously untreated, older adult patients with acute myelogenous leukemia (AML) who are unlikely to benefit from standard induction therapy. This is Genzyme's second pivotal clinical study of clofarabine in adult patients with AML to commence this year. StemCells...
- Getting to the root of beautiful hair: shiny, silky hair begins with a healthy scalp - includes list of resources and a recipe for an herbal scalp tonic
- Made from scratch: When Honda built a plant in Alabama it also built a workforce-using local workers who had no experience in making cars - Recruitment & Hiring
- Portfolio forecasting tools: what you need to know
- Industry Experts Launch Money Management Resources to Help People Overcome Debt and Learn Proper Money Management Practices
- Why fly solo when an executive assistant can accelerate your CLNC® business?
- Banking technology, technological learning and competition: comparative case studies in Thai banking
- John Seely Brown Inducted Into 2004 Industry Hall of Fame
- SmartDisk's New VST Flash Media Reader(TM) Reads SmartMedia(TM), CompactFlash(TM) From A Single Desktop Unit